SMiR-NBI specifications


Unique identifier OMICS_29711
Alternative name Small Molecule-miRNA Network-Based Inference
Restrictions to use None
Community driven No
Data access File download, Browse
User data submission Not allowed
Maintained Yes


  • person_outline Yun Tang
  • person_outline Jianwen Liu

Additional information

Publication for Small Molecule-miRNA Network-Based Inference

SMiR-NBI institution(s)
Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, Shanghai, China; State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy, West China Hospital, West China Medical School, Sichuan University, Chengdu, China; Center for Cancer Systems Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Center for Complex Networks Research, Northeastern University, Boston, MA, USA
SMiR-NBI funding source(s)
Supported by the National Natural Science Foundation of China (Grant 81373329 and 81573020), the 863 Project (Grant 2012AA020308), the Fundamental Research Funds for the Central Universities (Grant WY1113007), and the 111 Project (Grant B07023).

SMiR-NBI review

star_border star_border star_border star_border star_border
star star star star star
Anonymous user #113096's avatar image

Anonymous user #113096

star_border star_border star_border star_border star_border
star star star star star
This database contained both validated and predicted links among small molecules, miRNAs and diseases, aimed at studying their relationships to identify pharmacogenomic biomarkers. This is a good resource to check the knowledge base and find potential relationships predicted by the high-performance NBI method and worth experimental validation.